Endocannabinoids and regulation of fertility

  • Mauro Maccarrone
Part of the Milestones in Drug Therapy MDT book series (MDT)


Sertoli Cell Fatty Acid Amide Hydrolase Mouse Uterus Uterine Epithelial Cell Fatty Acid Amide Hydrolase Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Das SK, Paria BC, Chalkraborty I, Day SK (1995) Cannabinoid ligand-receptor signaling in the mouse uterus. Proc Natl Acad Sci USA 92: 4332–4336PubMedGoogle Scholar
  2. 2.
    Ness RB, Grisso JA, Hirschinger N, Markovic N, Shaw LM, Day NL, Kline J (1999) Cocaine and tobacco use and the risk of spontaneous abortion. N Engl J Med 340: 333–339CrossRefPubMedGoogle Scholar
  3. 3.
    Paria BC, Dey SK (2000) Ligand-receptor signaling with endocannabinoids in preimplantation embryo development and implantation. Chem Phys Lipids 108: 211–220CrossRefPubMedGoogle Scholar
  4. 4.
    Maccarrone M, Falciglia K, Di Rienzo M, Finazzi-Agrò A (2002) Endocannabinoids, hormone-cytokine networks and human fertility. Prostaglandins, Leukotrienes and Essential Fatty Acids 66: 309–317Google Scholar
  5. 5.
    Schmid PC, Paria BC, Krebsbach RJ, Schmid HHO, Dey SK (1997) Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation. Proc Natl Acad Sci USA 94: 4188–4192CrossRefPubMedGoogle Scholar
  6. 6.
    Wang J, Paria BC, Dey SK, Armant DR (1999) Stage-specific excitation of cannabinoid receptor exhibits differential effects on mouse embryonic development. Biol Reprod 60: 839–844PubMedGoogle Scholar
  7. 7.
    Mani SK, Mitchell A, O’Malley BW (2001) Progesterone receptor and dopamine receptors are required in Δ9-tetrahydrocannabinol modulation of sexual receptivity in female rats. Proc Natl Acad Sci USA 98: 1249–1254CrossRefPubMedGoogle Scholar
  8. 8.
    Paria BC, Song H, Wang X, Schmid PC, Krebsbach RJ, Schmid HH, Bonner TI, Zimmer A, Dey SK (2001) Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation. J Biol Chem 276: 20523–20528CrossRefPubMedGoogle Scholar
  9. 9.
    Chang MC, Berkery D, Schuel R, Laychock SG, Zimmerman AM, Zimmerman S, Schuel H (1993) Evidence for a cannabinoid receptor in sea urchin sperm and its role in blockade of the acrosome reaction. Mol Reprod Dev 36: 507–516CrossRefPubMedGoogle Scholar
  10. 10.
    Schuel H, Goldstein E, Mechoulam R, Zimmerman AM, Zimmerman S (1994) Anandamide (arachidonylethanolamide), a brain cannabinoid receptor agonist, reduces sperm fertilizing capacity in sea urchins by inhibiting the acrosome reaction. Proc Natl Acad Sci USA 91: 7678–7682PubMedGoogle Scholar
  11. 11.
    Schuel H, Burkman LJ, Lippes J, Crickard K, Mahony MC, Giuffrida A, Picone RP, Makriyannis A (2002) Evidence that anandamide-signaling regulates human sperm functions required for fer-tilization. Mol Reprod Dev 63: 376–387CrossRefPubMedGoogle Scholar
  12. 12.
    Bracey MH, Hanson MA, Masuda KR, Stevens RC, Cravatt BF (2002) Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling. Science 298: 1793–1796CrossRefPubMedGoogle Scholar
  13. 13.
    Bisogno T, De Petrocellis L, Di Marzo V (2002) Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications. Curr Pharmaceut Design 8: 533–547CrossRefGoogle Scholar
  14. 14.
    Mechoulam R, Panikashvili D, Shohami E (2002) Cannabinoids and brain injury: therapeutic implications. Trends Mol Med 8: 58–61CrossRefPubMedGoogle Scholar
  15. 15.
    Cravatt BF, Lichtman AH (2003) Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. Curr Opin Chem Biol 7: 469–475CrossRefPubMedGoogle Scholar
  16. 16.
    Guzman M (2003) Cannabinoids: Potential anticancer agents. Nature Rev Cancer 3: 745–755CrossRefGoogle Scholar
  17. 17.
    Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A, Mor M, Tarzia G, La Rana G, Malignano A et al. (2003) Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9: 76–81CrossRefPubMedGoogle Scholar
  18. 18.
    Paria BC, Deutsch DD, Dey SK (1996) The uterus is a potential site for anandamide synthesis and hydrolysis: differential profiles of anandamide synthase and hydrolase activities in the mouse uterus during the periimplantation period. Mol Rep Dev 45: 183–192CrossRefGoogle Scholar
  19. 19.
    Paria BC, Zhao X, Wang J, Das SK, Dey SK (1999) Fatty-acid amide hydrolase is expressed in the mouse uterus and embryo during the periimplantation period. Biol Reprod 60: 1151–1157PubMedGoogle Scholar
  20. 20.
    Maccarrone M, De Felici M, Bari M, Klinger F, Siracusa G, Finazzi-Agrò A (2000) Down-regulation of anandamide hydrolase in mouse uterus by sex hormones. Eur J Biochem 267: 2991–2997PubMedGoogle Scholar
  21. 21.
    Venance L, Piomelli D, Glowinski J, Giaume C (1995) Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes. Nature 376: 590–594CrossRefPubMedGoogle Scholar
  22. 22.
    Boger DL, Patterson JE, Guan X, Cravatt BF, Lerner RA, Gilula NB (1998) Chemical requirements for inhibition of gap junction communication by the biologically active lipid oleamide. Proc Natl Acad Sci USA 95: 4810–4815CrossRefPubMedGoogle Scholar
  23. 23.
    Paria BC, Ma W, Andrenyak DM, Schmid PC, Schmid HH, Moody DE, Deng H, Makriyannis A, Dey SK (1998) Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors. Biol Reprod 58: 1490–1495PubMedGoogle Scholar
  24. 24.
    Wang H, Matsumoto H, Guo Y, Paria BC, Roberts RL, Dey SK (2003) Differential G protein-coupled cannabinoid receptor signaling by anandamide directs blastocyst activation for implantation. Proc Natl Acad Sci USA 100: 14914–14919CrossRefPubMedGoogle Scholar
  25. 25.
    Maccarrone M, Bisogno T, Valensise H, Lazzarin N, Fezza F, Manna C, Di Marzo V, Finazzi-Agrb A (2002) Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer. Mol Hum Reprod 8: 188–195CrossRefPubMedGoogle Scholar
  26. 26.
    Schuel H, Burkman LJ, Lippes J, Crickard K, Forester E, Piomelli D, Giuffrida A (2002) N-Acylethanolamines in human reproductive fluids. Chem Phys Lipids 121: 211–227CrossRefPubMedGoogle Scholar
  27. 27.
    Piccinni MP, Beloni L, Livi C, Maggi E, Scarselli G, Romagnani S (1998) Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat Med 4: 1020–1024CrossRefPubMedGoogle Scholar
  28. 28.
    Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR, Lichtman AH (2001) Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci USA 98: 9371–9376CrossRefPubMedGoogle Scholar
  29. 29.
    Maccarrone M, Valensise H, Bari M, Lazzarin N, Romanini C, Finazzi-Agrò A (2000) Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage. Lancet 355: 1326–1329CrossRefPubMedGoogle Scholar
  30. 30.
    Maccarrone M, Valensise H, Bari M, Lazzarin N, Romanini C, Finazzi-Agrò A (2001) Progesterone up-regulates anandamide hydrolase in human lymphocytes. Role of cytokines and implications for fertility. J Immunol 166: 7183–7189PubMedGoogle Scholar
  31. 31.
    Lazzarin N, Valensise H, Bari M, Ubaldi F, Battista N, Finazzi-Agrò A, Maccarrone M (2004) Fluctuations of fatty acid amide hydrolase and anandamide levels during the human ovulatory cycle. Gynecol Endocrinol 18: 212–218CrossRefPubMedGoogle Scholar
  32. 32.
    Maccarrone M, Bari M, Di Rienzo M, Finazzi-Agrò A, Rossi A (2003) Progesterone activates fatty acid amide hydrolase (FAAH) promoter in human T lymphocytes through the transcription factor Ikaros. Evidence for a synergistic effect of leptin. J Biol Chem 278: 32726–32732CrossRefPubMedGoogle Scholar
  33. 33.
    Ahima RS, Flier JS (2000) Leptin. Annu Rev Physiol 62: 413–437CrossRefPubMedGoogle Scholar
  34. 34.
    Matarese G, La Cava A, Sanna V, Lord GM, Lechler RI, Fontana S, Zappacosta S (2002) Balancing susceptibility to infection and autoimmunity: a role for leptin? Trends Immunol 23: 182–187CrossRefPubMedGoogle Scholar
  35. 35.
    Hall W, Solowij N (1998) Adverse effects of cannabis. Lancet 352: 1611–1616CrossRefPubMedGoogle Scholar
  36. 36.
    Ambrosini A, Zolese G, Wozniak M, Genga D, Boscaro M, Mantero F, Balercia G (2003) Idiopathic infertility: susceptibility of spermatozoa to in vitro capacitation, in the presence and the absence of palmitylethanolamide (a homologue of anandamide), is strongly correlated with membrane polarity studied by Laurdan fluorescence. Mol Hum Reprod 9: 381–388CrossRefPubMedGoogle Scholar
  37. 37.
    Sugiura T, Kondo S, Sukagawa A, Tonegawa T, Nakane S, Yamashita A, Waku K (1996) Enzymatic synthesis of anandamide an endogenous cannabinoid receptor ligand through N-acylphosphatidylethanolamine pathway in testis: involvement of Ca2+-dependent transacylase and phosphodiesterase activities. Biochem Biophys Res Commun 218: 113–117CrossRefPubMedGoogle Scholar
  38. 38.
    Wenger T, Ledent C, Csernus V, Gerendai I (2001) The central cannabinoid receptor inactivation suppresses endocrine reproductive functions. Biochem Biophys Res Commun 284: 363–368CrossRefPubMedGoogle Scholar
  39. 39.
    Newton SC, Murphy LL, Bartke A (1993) In vitro effects of psychoactive and non-psychoactive cannabinoids on immature rat Sertoli cell function. Life Sci 53: 1429–1434CrossRefPubMedGoogle Scholar
  40. 40.
    Orth JM, McGuinness MP, Qiu J, Jester WF Jr, Li LH (1998) Use of in vitro systems to study male germ cell development in neonatal rats. Theriogenology 49: 431–439CrossRefPubMedGoogle Scholar
  41. 41.
    Maccarrone M, Cecconi S, Rossi G, Battista N, Pauselli R, Finazzi-Agrò A (2003) Anandamide activity and degradation are regulated by early postnatal ageing and follicle-stimulating hormone in mouse Sertoli cells. Endocrinology 144: 20–28CrossRefPubMedGoogle Scholar
  42. 42.
    O’Bryan MK, Schlatt S, Gerdprasert O, Phillips DJ, de Kretser DM, Hedger MP (2000) Inducible nitric oxide synthase in the rat testis: evidence for potential roles in both normal function and inflammation-mediated infertility. Biol Reprod 63: 1285–1293PubMedGoogle Scholar
  43. 43.
    Herrero MB, de Lamirande E, Gagnon C (2001) Tyrosine nitration in human spermatozoa: a physiological function of peroxynitrite, the reaction product of nitric oxide and superoxide. Mol Hum Reprod 7: 913–921CrossRefPubMedGoogle Scholar
  44. 44.
    Fujisawa M, Yamanaka K, Tanaka H, Tanaka H, Okada H, Arakawa S, Kamidono S (2001) Expression of endothelial nitric oxide synthase in the Sertoli cells of men with infertility of various causes. BJU Int 87: 85–88CrossRefPubMedGoogle Scholar
  45. 45.
    Tapanainen JS, Aittomaki K, Min J, Vaskivmo T, Huhtaniemi I (1997) Men homozygous for an inactivating mutation of the follicle stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility. Nat Genet 15: 205–206CrossRefPubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag/Switzerland 2005

Authors and Affiliations

  • Mauro Maccarrone
    • 1
  1. 1.Department of Biomedical SciencesUniversity of TeramoTeramoItaly

Personalised recommendations